C12Y 305/03006
Arginine deiminase
Official title: Arginine deiminase (3.5.3.6)
C12Y305/03006 (Arginine deiminase) appears on 40 US grants and 55 published applications in this corpus.
Search patents in C12Y- Granted patents
- 40
- Published applications
- 55
- Assignees
- 35
- Inventors
- 123
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 2 | 1 |
| 2004 | 1 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 2 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 2 |
| 2015 | 1 | 2 |
| 2016 | 2 | 5 |
| 2017 | 3 | 3 |
| 2018 | 3 | 6 |
| 2019 | 3 | 2 |
| 2020 | 4 | 2 |
| 2021 | 3 | 7 |
| 2022 | 3 | 3 |
| 2023 | 0 | 3 |
| 2024 | 2 | 3 |
| 2025 | 6 | 2 |
| 2026 | 3 | 5 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Fluorescent biosensor for rapid determination of l-arginine2 Jun 2026US 12,644,110 B2The Hong Kong Polytechnic University
- Methods for predicting response to arginine deprivation therapy based on plasma arginine levels in cancer patients10 Mar 2026US 12,569,488 B2Polaris Pharmaceuticals, Inc.
- Anti-PAD2 antibody24 Feb 2026US 12,559,570 B2Pharma Foods International Co., Ltd.
- Compositions and methods of use thereof for treatment of metabolic diseases and related disorders30 Dec 2025US 12,508,306 B2Washington University
- Method for preparing immobilized arginine deiminase (ADI) and producing [14/15N]-L-citrulline5 Aug 2025US 12,378,563 B2Shanghai University of Medicine & Health Sciences
- Arginine deiminase mutant, covalent dimer and conjugate and use thereof13 Aug 2026US 2026/0234595 A1Peg-Bio Biopharm Co.,Ltd.(Chongqing)
- Formulations of pegylated arginine deiminase30 Jul 2026US 2026/0216304 A1Polaris Group
- Novel anti-pad2 antibody4 Jun 2026US 2026/0152572 A1Pharma Foods International Co., Ltd.
- Compositions and methods of use thereof for treatment of metabolic diseases and related disorders5 Mar 2026US 2026/0061040 A1Washington University
- Genetically modified bacteria for generating vaccines19 Feb 2026US 2026/0048107 A1Baccine Ltd.
Most cited
By later US patents
- Modified arginine deiminase102US 6,183,738 B2Phoenix Pharamacologics, Inc. · 2001
- Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same19US 6,645,739 B2Phoenix Pharmacologies, Inc. · 2003
- Mutated form of arginine deiminase18US 6,635,462 B1Phoenix Pharmacologies, Inc. · 2003
- Modified arginine deiminase17US 6,737,259 B1Phoenix Pharmacologics, Inc. · 2004
- Erythrocytes containing arginine deiminase15US 9,125,876 B2Erytech Pharma · 2015